Limits...
Assessment of allergen-induced respiratory hyperresponsiveness before the prescription of a specific immunotherapy.

Olivier CE, Argentão DG, Dos Santos Lima RP, da Silva MD, Dos Santos RA, Fabbri N - Allergy Rhinol (Providence) (2015)

Bottom Line: The differences between the pre- and postspirometric estimated values of peak expiratory flow rate (PEFdif%), forced expiratory volume in 1 second (FEV1dif%), and forced vital capacity (FVCdif%) were correlated with the results of the nasal provocation test symptom score (NPT-SS).There were 119 subjects (69%) with NPT-SS > 2.The Spearman's correlation between PEFdif% and NPT-SS was r = -0.44 (p = 0.01); the Spearman's correlation between FEV1dif% and NPT-SS was r = -0.22 (p = 0.01), and the Spearman's correlation between FVCdif% and NPT-SS was r = -0.21 (p = 0.04).

View Article: PubMed Central - PubMed

Affiliation: Instituto Alergoimuno de Americana, São Paulo, Brazil.

ABSTRACT

Background: Asymptomatic sensitization is a frequent condition that must be considered before the indication of allergic-specific immunotherapy.

Objective: The aim of this study was to appreciate and correlate the local and spirometric changes elicited by the allergen-specific nasal provocation test (NPT) to define practical and feasible guidelines for the allergist/immunologist to demonstrate specific respiratory hyperresponsiveness before the indication of allergic-specific immunotherapy.

Methods: A total of 172 subjects (children and adults) with a diagnosis of allergic rhinitis were submitted to flow-volume spirometry immediately before and after the NPT performed with Dermatophagoides antigens. The differences between the pre- and postspirometric estimated values of peak expiratory flow rate (PEFdif%), forced expiratory volume in 1 second (FEV1dif%), and forced vital capacity (FVCdif%) were correlated with the results of the nasal provocation test symptom score (NPT-SS).

Results: There were 119 subjects (69%) with NPT-SS > 2. Among these patients who were reactive, the mean NPT-SS was 6.3. The Spearman's correlation between PEFdif% and NPT-SS was r = -0.44 (p = 0.01); the Spearman's correlation between FEV1dif% and NPT-SS was r = -0.22 (p = 0.01), and the Spearman's correlation between FVCdif% and NPT-SS was r = -0.21 (p = 0.04).

Conclusion: The combined utilization of the allergen-specific NPT-SS with the spirometry (or PEF meter) is a safe methodology to evaluate allergen-specific nasal and bronchial hyperresponsiveness (which sometimes acts as a bronchial provocation test) in patients with allergic rhinitis and asthma due to hypersensitivity who are candidates for allergen-specific immunotherapy.

No MeSH data available.


Related in: MedlinePlus

A paired correlation chart between the symptom score of the NPT with D. pteronyssinus and the FEV1 relative decrease after NPT in subjects with allergic rhinitis and a decrease in FEV1 ≥ 1%.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4541640&req=5

Figure 2: A paired correlation chart between the symptom score of the NPT with D. pteronyssinus and the FEV1 relative decrease after NPT in subjects with allergic rhinitis and a decrease in FEV1 ≥ 1%.

Mentions: Two subjects (1.1%) had a decrease of FEV1 ≥ 20%. Among these subjects, the mean FEV1dif% was 22.5%. There were 5 subjects (2.9%) who had a decrease of FEV1 ≥ 15%. Among these subjects, the mean FEV1dif% was 15.4%. There were 112 subjects (65.1%) who had a decrease of FEV1 ≥ 1%. Among these subjects, the mean FEV1dif% was = 4.4%. In this group, the Spearman's correlation between FEV1dif% and NPT-SS was r = − 0.22 (p = 0.01) (Fig. 2).


Assessment of allergen-induced respiratory hyperresponsiveness before the prescription of a specific immunotherapy.

Olivier CE, Argentão DG, Dos Santos Lima RP, da Silva MD, Dos Santos RA, Fabbri N - Allergy Rhinol (Providence) (2015)

A paired correlation chart between the symptom score of the NPT with D. pteronyssinus and the FEV1 relative decrease after NPT in subjects with allergic rhinitis and a decrease in FEV1 ≥ 1%.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4541640&req=5

Figure 2: A paired correlation chart between the symptom score of the NPT with D. pteronyssinus and the FEV1 relative decrease after NPT in subjects with allergic rhinitis and a decrease in FEV1 ≥ 1%.
Mentions: Two subjects (1.1%) had a decrease of FEV1 ≥ 20%. Among these subjects, the mean FEV1dif% was 22.5%. There were 5 subjects (2.9%) who had a decrease of FEV1 ≥ 15%. Among these subjects, the mean FEV1dif% was 15.4%. There were 112 subjects (65.1%) who had a decrease of FEV1 ≥ 1%. Among these subjects, the mean FEV1dif% was = 4.4%. In this group, the Spearman's correlation between FEV1dif% and NPT-SS was r = − 0.22 (p = 0.01) (Fig. 2).

Bottom Line: The differences between the pre- and postspirometric estimated values of peak expiratory flow rate (PEFdif%), forced expiratory volume in 1 second (FEV1dif%), and forced vital capacity (FVCdif%) were correlated with the results of the nasal provocation test symptom score (NPT-SS).There were 119 subjects (69%) with NPT-SS > 2.The Spearman's correlation between PEFdif% and NPT-SS was r = -0.44 (p = 0.01); the Spearman's correlation between FEV1dif% and NPT-SS was r = -0.22 (p = 0.01), and the Spearman's correlation between FVCdif% and NPT-SS was r = -0.21 (p = 0.04).

View Article: PubMed Central - PubMed

Affiliation: Instituto Alergoimuno de Americana, São Paulo, Brazil.

ABSTRACT

Background: Asymptomatic sensitization is a frequent condition that must be considered before the indication of allergic-specific immunotherapy.

Objective: The aim of this study was to appreciate and correlate the local and spirometric changes elicited by the allergen-specific nasal provocation test (NPT) to define practical and feasible guidelines for the allergist/immunologist to demonstrate specific respiratory hyperresponsiveness before the indication of allergic-specific immunotherapy.

Methods: A total of 172 subjects (children and adults) with a diagnosis of allergic rhinitis were submitted to flow-volume spirometry immediately before and after the NPT performed with Dermatophagoides antigens. The differences between the pre- and postspirometric estimated values of peak expiratory flow rate (PEFdif%), forced expiratory volume in 1 second (FEV1dif%), and forced vital capacity (FVCdif%) were correlated with the results of the nasal provocation test symptom score (NPT-SS).

Results: There were 119 subjects (69%) with NPT-SS > 2. Among these patients who were reactive, the mean NPT-SS was 6.3. The Spearman's correlation between PEFdif% and NPT-SS was r = -0.44 (p = 0.01); the Spearman's correlation between FEV1dif% and NPT-SS was r = -0.22 (p = 0.01), and the Spearman's correlation between FVCdif% and NPT-SS was r = -0.21 (p = 0.04).

Conclusion: The combined utilization of the allergen-specific NPT-SS with the spirometry (or PEF meter) is a safe methodology to evaluate allergen-specific nasal and bronchial hyperresponsiveness (which sometimes acts as a bronchial provocation test) in patients with allergic rhinitis and asthma due to hypersensitivity who are candidates for allergen-specific immunotherapy.

No MeSH data available.


Related in: MedlinePlus